BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19360359)

  • 1. Se-methylselenocysteine sensitized TRAIL-mediated apoptosis via down-regulation of Bcl-2 expression.
    Lee JT; Lee TJ; Park JW; Kwon TK
    Int J Oncol; 2009 May; 34(5):1455-60. PubMed ID: 19360359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylseleninic acid sensitizes prostate cancer cells to TRAIL-mediated apoptosis.
    Yamaguchi K; Uzzo RG; Pimkina J; Makhov P; Golovine K; Crispen P; Kolenko VM
    Oncogene; 2005 Sep; 24(38):5868-77. PubMed ID: 15897871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low concentrations of doxorubicin sensitizes human solid cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-receptor (R) 2-mediated apoptosis by inducing TRAIL-R2 expression.
    Wu XX; Jin XH; Zeng Y; El Hamed AM; Kakehi Y
    Cancer Sci; 2007 Dec; 98(12):1969-76. PubMed ID: 17922852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo.
    Vogler M; Walczak H; Stadel D; Haas TL; Genze F; Jovanovic M; Gschwend JE; Simmet T; Debatin KM; Fulda S
    Cancer Res; 2008 Oct; 68(19):7956-65. PubMed ID: 18829553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silibinin sensitizes human glioma cells to TRAIL-mediated apoptosis via DR5 up-regulation and down-regulation of c-FLIP and survivin.
    Son YG; Kim EH; Kim JY; Kim SU; Kwon TK; Yoon AR; Yun CO; Choi KS
    Cancer Res; 2007 Sep; 67(17):8274-84. PubMed ID: 17804742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triptolide sensitizes resistant cholangiocarcinoma cells to TRAIL-induced apoptosis.
    Panichakul T; Intachote P; Wongkajorsilp A; Sripa B; Sirisinha S
    Anticancer Res; 2006; 26(1A):259-65. PubMed ID: 16475706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of apoptosis by Se-MSC in U937 human leukemia cells through release of cytochrome c and activation of caspases and PKC-delta: mutual regulation between caspases and PKC-delta via a positive feedback mechanism.
    Jang BC; Choi ES; Im KJ; Baek WK; Kwon TK; Suh MH; Kim SP; Park JW; Suh SI
    Int J Mol Med; 2003 Nov; 12(5):733-9. PubMed ID: 14533002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing of prion protein sensitizes breast adriamycin-resistant carcinoma cells to TRAIL-mediated cell death.
    Meslin F; Hamaï A; Gao P; Jalil A; Cahuzac N; Chouaib S; Mehrpour M
    Cancer Res; 2007 Nov; 67(22):10910-9. PubMed ID: 18006836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mitochondrial block and expression of XIAP lead to resistance to TRAIL-induced apoptosis during progression to metastasis of a colon carcinoma.
    Ndozangue-Touriguine O; Sebbagh M; Mérino D; Micheau O; Bertoglio J; Bréard J
    Oncogene; 2008 Oct; 27(46):6012-22. PubMed ID: 18560353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Troglitazone sensitizes tumor cells to TRAIL-induced apoptosis via down-regulation of FLIP and Survivin.
    Schultze K; Böck B; Eckert A; Oevermann L; Ramacher D; Wiestler O; Roth W
    Apoptosis; 2006 Sep; 11(9):1503-12. PubMed ID: 16820965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenic trioxide sensitizes human glioma cells, but not normal astrocytes, to TRAIL-induced apoptosis via CCAAT/enhancer-binding protein homologous protein-dependent DR5 up-regulation.
    Kim EH; Yoon MJ; Kim SU; Kwon TK; Sohn S; Choi KS
    Cancer Res; 2008 Jan; 68(1):266-75. PubMed ID: 18172319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sanguinarine-induced apoptosis: generation of ROS, down-regulation of Bcl-2, c-FLIP, and synergy with TRAIL.
    Kim S; Lee TJ; Leem J; Choi KS; Park JW; Kwon TK
    J Cell Biochem; 2008 Jun; 104(3):895-907. PubMed ID: 18189268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quercetin sensitizes human hepatoma cells to TRAIL-induced apoptosis via Sp1-mediated DR5 up-regulation and proteasome-mediated c-FLIPS down-regulation.
    Kim JY; Kim EH; Park SS; Lim JH; Kwon TK; Choi KS
    J Cell Biochem; 2008 Dec; 105(6):1386-98. PubMed ID: 18980244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mcl-1: a gateway to TRAIL sensitization.
    Kim SH; Ricci MS; El-Deiry WS
    Cancer Res; 2008 Apr; 68(7):2062-4. PubMed ID: 18381408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of normal and colon cancer epithelial cells to TNF-family apoptotic inducers.
    Hofmanová J; Vaculová A; Hyzd'alová M; Kozubík A
    Oncol Rep; 2008 Feb; 19(2):567-73. PubMed ID: 18202809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trichostatin A sensitizes TRAIL-resistant myeloma cells by downregulation of the antiapoptotic Bcl-2 proteins.
    Fandy TE; Srivastava RK
    Cancer Chemother Pharmacol; 2006 Oct; 58(4):471-7. PubMed ID: 16435155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproic acid sensitizes K562 erythroleukemia cells to TRAIL/Apo2L-induced apoptosis.
    Iacomino G; Medici MC; Russo GL
    Anticancer Res; 2008; 28(2A):855-64. PubMed ID: 18507029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 15-Deoxy-delta 12,14-prostaglandin J2 (15d-PGJ 2) sensitizes human leukemic HL-60 cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through Akt downregulation.
    Han H; Shin SW; Seo CY; Kwon HC; Han JY; Kim IH; Kwak JY; Park JI
    Apoptosis; 2007 Nov; 12(11):2101-14. PubMed ID: 17786557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A small molecule Smac mimic potentiates TRAIL-mediated cell death of ovarian cancer cells.
    Petrucci E; Pasquini L; Petronelli A; Saulle E; Mariani G; Riccioni R; Biffoni M; Ferretti G; Benedetti-Panici P; Cognetti F; Scambia G; Humphreys R; Peschle C; Testa U
    Gynecol Oncol; 2007 May; 105(2):481-92. PubMed ID: 17292950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Se-methylselenocysteine induces apoptosis through caspase activation and Bax cleavage mediated by calpain in SKOV-3 ovarian cancer cells.
    Yeo JK; Cha SD; Cho CH; Kim SP; Cho JW; Baek WK; Suh MH; Kwon TK; Park JW; Suh SI
    Cancer Lett; 2002 Aug; 182(1):83-92. PubMed ID: 12175527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.